Subscribe to Take Into Account knowledge hub
Under current ASC 820 guidance, a contractual sale restriction on an equity security is considered a characteristic of the reporting entity holding the security rather than a characteristic of the security itself. As a result, an entity generally does not consider the effect of that restriction when measuring the fair value of the equity security and does not recognize the restriction as a separate unit of account.
The FASB clarified that guidance in ASU 2022-03 to reduce diversity in practice. However, stakeholders later told the board that excluding contractual sale restrictions from fair value measurements can result in measurements that do not reflect market prices or economic reality. Those concerns can be especially significant for investment companies because fair value measurements directly affect net asset value (NAV), which might be overstated, as well as performance reporting, management fee calculations, and the prices at which investors purchase and redeem fund shares.
In response, the FASB approved a narrow exception for investment companies within the scope of ASC 946 “Financial Services – Investment Companies,” that hold equity securities measured at fair value and subject to contractual sale restrictions.
ASU 2026-03, “Fair Value Measurement (Topic 820): Investment Companies With Equity Securities Subject to Contractual Sale Restrictions,” requires an investment company within the scope of Topic 946 to incorporate the effect of a contractual sale restriction when measuring the fair value of an equity security. The discount reflects the amount market participants would demand because of the risk related to the inability to sell the security during the restriction period.
The ASU does not require investment companies to consider restrictions when their economics are reflected in another transaction, such as equity securities pledged as collateral in a borrowing arrangement.
Crowe observation: Affected investment companies might need to revisit valuation policies, pricing inputs, and controls over discounts for contractual sale restrictions. Rather than being a simple mechanical or policy-based discount, the discount would need to reflect market participant assumptions about liquidity risk during the restriction period.
The ASU also requires investment companies to disclose the amount of the discount attributable to contractual sale restrictions included in the fair value measurement of equity securities. If an investment company has multiple affected investments, it would consider existing Topic 820 disclosure aggregation guidance when determining the appropriate level of detail.
ASU 2026-03 is effective for investment companies for annual reporting periods beginning after Dec. 15, 2027, including interim periods within those annual periods. Early adoption is permitted on any date on or after Sept. 9, 2026.
Affected investment companies must apply the ASU prospectively to all equity securities beginning on the date of adoption, including securities subject to contractual sale restrictions existing at adoption. Any adjustment from adoption would be recognized in current-period earnings, and the investment company would disclose the amount recognized.
Crowe observation: The ASU’s transition approach could create an immediate earnings and NAV effect at adoption because the amendments would apply prospectively to all equity securities, including securities subject to existing contractual sale restrictions. Investment companies with significant restricted equity investments might want to inventory those holdings and evaluate potential adoption effects.
FASB materials reprinted with permission. Copyright 2026 by Financial Accounting Foundation, Norwalk, Connecticut. Copyright 1974-1980 by American Institute of Certified Public Accountants.